Gaze-contingent music reward therapy for social anxiety

针对社交焦虑的注视相关音乐奖励疗法

基本信息

项目摘要

Social anxiety disorder (SAD) is one of the most common psychiatric disorders, with a 5-13% lifetime prevalence and high chronicity and impairment. New treatments are needed for SAD, because current first-line treatments, such as cognitive behavioral therapy and serotonin reuptake inhibitors, fail half of patients. Attention allocation has emerged as a promising target because in SAD it is biased toward threat, and it can be objectively assessed and modified systematically. Prior studies of attention bias modification, however, have averaged only small effects. Our eye-tracking-based gaze-contingent music reward therapy (GC-MRT) targets sustained attention allocation and addresses limitations of prior attention bias modification therapies: It uses complex stimuli of photo montages of 16 competing threat and non-threat faces that foster transfer to real life situations. It directly trains sustained attention by using eye tracking to detect visual attention and to train it as it occur. It incorporates music chosen by the patient, which enhances task engagement. Its overall effect on attention allocation appears to involve two processes: a) reinforcing gaze at non-threat faces with reward (music); b) training attention away from threat faces. Preliminary data suggest that GC-MRT has large effects on attention allocation and that these changes partially mediate large effects on symptomatic improvement. The R61 phase will optimize the dose of GC-MRT by testing whether an extended 8-week course of treatment has greater effects than the standard 4-week course, and it will test whether GC-MRT engages the target of attention allocation, measured by the % of eye gaze dwell time on threat faces relative to overall dwell time on faces. It will also use fMRI to explore the impact of GC-MRT on neural processes of attention control and reward processing. In the R61, 40 adults with SAD will be randomized to the two doses of GC-MRT. The R61 progression criterion will be based on a clinically meaningful change in attention allocation, as assessed by mean % dwell time on threat faces during the last session, relative to baseline. The R33 phase will test in a randomized controlled trial whether GC-MRT improves symptoms and quality of life in persons with SAD, and if change in attention allocation predicts change in SAD symptoms. It will also explore whether neural and behavioral measures of attentional control and reward processing change with treatment and are associated with symptomatic improvement. In the R33, 80 adults with SAD will be randomized to GC-MRT versus a control therapy that is identical except for non-contingent continuous music (all will get the same number of sessions, based on R61 dose-finding outcome). Positive findings in the R33 will be the basis for a confirmatory R01 randomized controlled trial, advancing further development of this novel brief low-cost treatment for social anxiety that could be adapted for virtual reality devices with potential for wide dissemination. Negative findings would clarify the mechanisms involved in GC-MRT and lead to reformulation of GC-MRT directed at the processes most relevant to symptomatic improvement.
社交焦虑障碍(SAD)是最常见的精神障碍之一,其终生发病率为5-13%

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Resting state connectivity predictors of symptom change during gaze-contingent music reward therapy of social anxiety disorder.
  • DOI:
    10.1017/s0033291721005171
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Zhu, Xi;Lazarov, Amit;Dolan, Sarah;Bar-Haim, Yair;Dillon, Daniel G.;Pizzagalli, Diego A.;Schneier, Franklin
  • 通讯作者:
    Schneier, Franklin
Neurophysiological predictors of gaze-contingent music reward therapy among adults with social anxiety disorder.
  • DOI:
    10.1016/j.jpsychires.2021.09.022
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Umemoto A;Cole SL;Allison GO;Dolan S;Lazarov A;Auerbach RP;Schneier F
  • 通讯作者:
    Schneier F
Increased attention allocation to socially threatening faces in social anxiety disorder: A replication study.
  • DOI:
    10.1016/j.jad.2021.04.063
  • 发表时间:
    2021-07-01
  • 期刊:
  • 影响因子:
    6.6
  • 作者:
    Lazarov A;Basel D;Dolan S;Dillon DG;Pizzagalli DA;Schneier FR
  • 通讯作者:
    Schneier FR
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Franklin R. Schneier其他文献

Franklin R. Schneier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Franklin R. Schneier', 18)}}的其他基金

Targeting Dopamine-Mediated Social Reward Sensitivity to Remediate Social Disconnection
针对多巴胺介导的社会奖励敏感性来修复社会脱节
  • 批准号:
    10572245
  • 财政年份:
    2023
  • 资助金额:
    $ 65.61万
  • 项目类别:
Gaze-contingent music reward therapy for social anxiety
针对社交焦虑的注视相关音乐奖励疗法
  • 批准号:
    10392334
  • 财政年份:
    2018
  • 资助金额:
    $ 65.61万
  • 项目类别:
Ventrostriatal Dopamine Release and Reward Motivation in MDD
MDD 中的腹纹状体多巴胺释放和奖励动机
  • 批准号:
    8891167
  • 财政年份:
    2014
  • 资助金额:
    $ 65.61万
  • 项目类别:
Ventrostriatal Dopamine Release and Reward Motivation in MDD
MDD 中的腹纹状体多巴胺释放和奖励动机
  • 批准号:
    8579490
  • 财政年份:
    2013
  • 资助金额:
    $ 65.61万
  • 项目类别:
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
米氮平和 SSRI 联合治疗 PTSD:安慰剂对照试验
  • 批准号:
    7978835
  • 财政年份:
    2010
  • 资助金额:
    $ 65.61万
  • 项目类别:
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
米氮平和 SSRI 联合治疗 PTSD:安慰剂对照试验
  • 批准号:
    8254449
  • 财政年份:
    2010
  • 资助金额:
    $ 65.61万
  • 项目类别:
Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial
米氮平和 SSRI 联合治疗 PTSD:安慰剂对照试验
  • 批准号:
    8103124
  • 财政年份:
    2010
  • 资助金额:
    $ 65.61万
  • 项目类别:
Neural circuitry of submissive behavior and treatment response in social anxiety
社交焦虑中顺从行为和治疗反应的神经回路
  • 批准号:
    7256857
  • 财政年份:
    2007
  • 资助金额:
    $ 65.61万
  • 项目类别:
Neural circuitry of submissive behavior and treatment response in social anxiety
社交焦虑中顺从行为和治疗反应的神经回路
  • 批准号:
    7394457
  • 财政年份:
    2007
  • 资助金额:
    $ 65.61万
  • 项目类别:
Combination Treatment for PTSD After the WTC Attack
世贸中心袭击后 PTSD 的联合治疗
  • 批准号:
    7210753
  • 财政年份:
    2004
  • 资助金额:
    $ 65.61万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 65.61万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了